Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2026 09:42 ET | Source: BCC Research LLC

Chronic Kidney Disease Market to Reach $131.4 Billion by 2030, Driven by Rising Prevalence and Healthcare Infrastructure Investment

Examines the evolving competitive landscape, regulatory developments & investment trends shaping the future of chronic kidney disease management worldwide.
July 02, 2026 09:05 ET | Source: Myriad Genetics, Inc.

New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer

New published data shows Prolaris Biopsy Test adds significant prognostic information beyond conventional clinical risk categories for prostate cancer.
June 30, 2026 07:30 ET | Source: FocalTherics (TM)

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- ...
June 22, 2026 17:00 ET | Source: A3P Biomedical

Pioneering screening test offers potential to find more aggressive prostate cancers

Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancer.
June 18, 2026 10:12 ET | Source: BCC Research LLC

AI Transforms Chronic Kidney Disease Management as Healthcare Investment Accelerates Globally

Growing role of machine learning, deep learning and predictive analytics in addressing clinical, operational and economic challenges in kidney care.
June 16, 2026 07:30 ET | Source: FocalTherics (TM)

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics...
June 09, 2026 09:07 ET | Source: Alembic Therapeutics

Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.

Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
June 03, 2026 09:00 ET | Source: Coloplast A/S

Coloplast’s Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of men

The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
May 29, 2026 07:30 ET | Source: EDAP TMS S.A.

EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy

EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June...
May 21, 2026 07:30 ET | Source: EDAP TMS S.A.

EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference

, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Thursday, June 4th, 2026 AUSTIN,...